Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Optimizing ceftolozane-tazobac...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights

Bibliographic Details
Main Authors: Patrick M. Honore, Aude Mugisha, Leonel Barreto Gutierrez, Sebastien Redant, Keitiane Kaefer, Andrea Gallerani, David De Bels
Format: Article
Language:English
Published: BMC 2019-12-01
Series:Critical Care
Online Access:https://doi.org/10.1186/s13054-019-2692-2
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://doi.org/10.1186/s13054-019-2692-2

Similar Items

  • Comparison between meropenem and ceftolozane/tazobactam: possible influence of CRRT
    by: Patrick M. Honore, et al.
    Published: (2022-01-01)
  • Dysbiosis of the microbiota in neurocritically ill patients associated with coma and death: ammonia as a potential missing link
    by: Patrick M. Honore, et al.
    Published: (2019-12-01)
  • Biomarker suPAR seems a good prognostic factor for community-acquired pneumonia but less prominent for septic shock
    by: Patrick M. Honore, et al.
    Published: (2019-12-01)
  • Interleukin-26 is a promising biomarker of sepsis but is it always reliable?
    by: Patrick M. Honore, et al.
    Published: (2019-12-01)
  • Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: some nuances
    by: Gerardo Aguilar, et al.
    Published: (2020-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs